Development of camelid single chain antibodies against Shiga toxin type 2 (Stx2) with therapeutic potential against Hemolytic Uremic Syndrome (HUS)

por Mejías, Maria P., Hiriart, Yanina, Lauché, Constanza, Fernández-Brando, Romina J., Pardo, Romina, Bruballa, Andrea, Ramos, María V., Goldbaum, Fernando A., Palermo, Marina S., Zylberman, Vanesa
Publicado 2016

Functional Capacity of Shiga-Toxin Promoter Sequences in Eukaryotic Cells

por Bentancor, Leticia V., Bilen, Marcos F., Mejías, María P., Fernández-Brando, Romina J., Panek, Cecilia A., Ramos, Maria V., Fernández, Gabriela C., Isturiz, Martín, Ghiringhelli, Pablo D., Palermo, Marina S.
Publicado 2013

Soluble CD40 Ligand and Oxidative Response Are Reciprocally Stimulated during Shiga Toxin-Associated Hemolytic Uremic Syndrome

por Abrey Recalde, Maria J., Alvarez, Romina S., Alberto, Fabiana, Mejias, Maria P., Ramos, Maria V., Fernandez Brando, Romina J., Bruballa, Andrea C., Exeni, Ramon A., Alconcher, Laura, Ibarra, Cristina A., Amaral, María M., Palermo, Marina S.
Publicado 2017